Oppenheimer Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Oppenheimer Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,087	Closed	-$277K	–	1658
2019 Q3	$277K	Sell	4,087 -71	-2%	-$4.88K	0.01%	968
2019 Q2	$242K	Sell	4,158 -685	-14%	-$40.6K	0.01%	1008
2019 Q1	$339K	Buy	+4,843	New	+$359K	0.01%	905

Oppenheimer Asset Management's GHDX Position: Q4 2019 in Review

Oppenheimer Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,087 shares — an estimated $277K sold.

Oppenheimer Asset Management first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $339K in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Oppenheimer Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Oppenheimer Asset Management sold 4,087 Genomic Health, Inc. shares in Q4 2019, an estimated $277K.
Oppenheimer Asset Management first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
Oppenheimer Asset Management's Genomic Health, Inc. position peaked at $339K in Q1 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Oppenheimer Asset Management's 13F filing for Q4 2019, filed 7 Feb 2020.